Financials
- Market Capitalization 2.04 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.3
Rapporto prezzo/fatturato
162.41
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1967 | VCEL Vericel Corporation - Common Stock | 40.96 USD | -0.53% | -4.03% | -12.08% | +12.68% | 2.10 B USD | ||
| 1969 | ADMA ADMA Biologics Inc - Common Stock | 9.35 USD | -1.37% | -4.98% | +7.35% | -46.26% | 2.09 B USD | ||
| 1990 | STOK Stoke Therapeutics, Inc. - Common Stock | 31.61 USD | -3.01% | -2.11% | +7.41% | +58.05% | 2.04 B USD | ||
| 1998 | ZYME Zymeworks Inc. - Common Stock | 28.28 USD | -2.52% | -1.36% | +24.80% | +59.41% | 2.01 B USD |